Gensol facilitates cross-border tech transfer between Europe and China, with long-term partnerships with Oxford and Exeter University. From Aug 30-Sept 4, 2025, we hosted Oxford’s Prof. Xia Zhidao and Exeter’s Prof. Helen Dawes and Dr. Thomas Richards visited China to engage in a series of in-depth discussions and exchanges on the introduction and implementation of frontier technologies, including bone repair materials, gait correction devices, and electromyographs.
Aug 30-Sept 1: New Materials Expo
Prof. Xia’s 3D-printed bone regeneration material was the highlight—it repairs bone defects, promotes natural growth, and fully integrates into the patient’s own bone within a year, offering precise treatment for severe fractures.

Sept 2: PKU Shenzhen Hospital Seminar
Prof. Dawes presented a gait correction device for stroke and ligament tear patients. It accurately identifies postoperative gait defects and provides data-driven rehabilitation support, earning strong clinical recognition.

Sept 3: Industry Meetings
After the technology showcase, gensol organized an expert team to engage with two health product manufacturers in Shenzhen, discussing technology implementation and laying the groundwork for future collaboration. They also visited CDMO company Guochuang Huikang to introduce project technologies and exchanged ideas with researchers from Xianjian Xinkan and Shenzhen Bay Laboratory on musculoskeletal device development. Additionally, the team reached a preliminary cooperation agreement with the Shenzhen Sports Medicine and Rehabilitation Medicine Concept Validation Center.

Sept 4: University & Investor Talks
The team visited Southern University of Science and Technology to explore collaboration mechanisms, met potential investors, and secured preliminary consensus with Guangzhou Yikang Medical on manufacturing and market strategy.

Future Outlook
Gensol will continue deepening China-Europe tech cooperation, incubating cross-disciplinary projects to help domestic industries break technological barriers and advance to high-end development.







